A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weekly

Assessment of response to therapy in advanced breast cancer

J.L. Hayward, Paul P. Carbone, J C Heusen et al. · British Journal of Cancer · 1977 · 706 citations · Full text

Medicine, Oncology, Breast Oncology +10

Small-Cell Carcinoma of the Lung: Combined Chemotherapy and Radiation

Robert B. Livingston, Terence N. Moore, Lance K. Heilbrun et al. · Annals of Internal Medicine · 1978 · 230 citations

Medicine, Oncology, Radiation Oncology +13

Small cell carcinoma of the lung

Livingston Rb · Blood · 1980 · 167 citations

Medicine, Oncology, Pathology +11

Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation.

Howard Gurney, Stephen P. Ackland, Val Gebski · Journal of Clinical Oncology · 1998 · 121 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A Novel Class of Chromophore-Modified Antitumor Anthracene-9,10-diones: Synthesis and Antitumor Evaluations

A. Paul Krapcho, M. E. PETRY, Zelleka Getahun et al. · Journal of Medicinal Chemistry · 1994 · 104 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10